The most recent preliminary estimates of incidence rates and trends are for 2000-2017. Users should refer to the official rates for 1975-2018 in SEER*Explorer, which was released in April 2021.
Analysis Methods
The delay model is applied to the February data to obtain delay-adjusted rates. To determine the trends, a Joinpoint model is then fit to the delay-adjusted rates.
Validation
To validate the use of the early February submission data for predicting the eventual rates and trends, the delay-adjusted rates derived from the November 2018 submission were compared to those from the February 2018 submission. The comparisons are based on (1) the delay-adjusted rates (2) the number of trend changes and (3) the most recent trend. If the comparisons between the two submissions of the same year yield similar results, it validates the use of February submission data for early estimation of incidence rates. In general, the February 2018 and November 2018 estimates are comparable, though some differences would be expected.
Validation Table
Cancer Site | Sex | Race | 2016 Age-Adjusted Rates | Annual Percent Change, 2000-2016 APC (Year Range) |
Average Annual Percent Change, 2012-2016 | |||||
---|---|---|---|---|---|---|---|---|---|---|
Observed | Delay-Adjusted | |||||||||
February 2018 Submission | November 2018 Submission | February 2018 Submission | November 2018 Submission | February 2018 Submission | November 2018 Submission | February 2018 Submission | November 2018 Submission | |||
* The APC/AAPC is significantly different from zero (p<0.05). | ||||||||||
All Sites | Male | All Races | 417.8 | 458.4 | 460.1 | 471.1 | -0.7* (2000-08) -2.1* (2008-16) | -0.7* (2000-08) -2.0* (2008-16) | -2.1* | -2.0* |
White | 419.7 | 462.0 | 468.1 | 478.2 | -0.6* (2000-08) -2.0* (2008-16) | -0.6* (2000-08) -1.9* (2008-16) | -2.0* | -1.9* | ||
Black | 448.9 | 501.3 | 509.7 | 527.8 | -1.3* (2000-09) -3.0* (2009-16) | -1.8* (2000-06) -0.2 (2006-09) -3.7* (2009-14) -0.2 (2014-16) | -3.0* | -1.9* | ||
Female | All Races | 377.4 | 402.1 | 414.0 | 412.9 | -0.0 (2000-16) | -0.1 (2000-16) | -0.0 | -0.1 | |
White | 389.3 | 415.2 | 432.3 | 429.4 | 0.0 (2000-16) | -0.0 (2000-16) | 0.0 | -0.0 | ||
Black | 360.8 | 388.4 | 408.4 | 408.8 | 0.1* (2000-16) | 0.1 (2000-16) | 0.1* | 0.1 | ||
All Sites (Ages 0-19) | Male | All Races | 18.1 | 19.2 | 19.5 | 19.6 | 0.7* (2000-16) | 0.7* (2000-16) | 0.7* | 0.7* |
White | 19.3 | 20.3 | 21.0 | 20.9 | 0.6* (2000-16) | 0.6* (2000-16) | 0.6* | 0.6* | ||
Black | 12.5 | 14.2 | 13.9 | 14.9 | 1.2* (2000-16) | 1.3* (2000-16) | 1.2* | 1.3* | ||
Female | All Races | 17.0 | 17.7 | 18.3 | 18.1 | 1.2* (2000-16) | 1.2* (2000-16) | 1.2* | 1.2* | |
White | 17.9 | 18.7 | 19.4 | 19.2 | 1.1* (2000-16) | 1.1* (2000-16) | 1.1* | 1.1* | ||
Black | 12.0 | 12.5 | 13.3 | 13.1 | 1.5* (2000-16) | 1.4* (2000-16) | 1.5* | 1.4* | ||
Brain and Other Nervous System | Male | All Races | 6.7 | 7.1 | 7.4 | 7.3 | -0.2* (2000-16) | -0.3* (2000-16) | -0.2* | -0.3* |
White | 7.4 | 7.8 | 8.3 | 8.1 | -0.1 (2000-16) | -0.2 (2000-16) | -0.1 | -0.2 | ||
Black | 4.0 | 4.3 | 4.5 | 4.5 | -0.1 (2000-16) | -0.2 (2000-16) | -0.1 | -0.2 | ||
Female | All Races | 4.6 | 4.9 | 5.1 | 5.1 | -0.2 (2000-16) | -0.3 (2000-16) | -0.2 | -0.3 | |
White | 5.1 | 5.5 | 5.8 | 5.7 | -0.1 (2000-16) | -0.2 (2000-16) | -0.1 | -0.2 | ||
Black | 2.8 | 3.2 | 3.2 | 3.3 | -0.6 (2000-16) | -0.6 (2000-16) | -0.6 | -0.6 | ||
Breast | Female | All Races | 119.5 | 124.6 | 125.3 | 126.6 | -2.3* (2000-04) 0.3* (2004-16) | -2.3* (2000-04) 0.3* (2004-16) | 0.3* | 0.3* |
White | 121.5 | 127.0 | 127.9 | 129.0 | -2.4* (2000-04) 0.2 (2004-16) | -2.5* (2000-04) 0.2 (2004-16) | 0.2 | 0.2 | ||
Black | 118.7 | 125.1 | 127.1 | 129.4 | 0.6* (2000-16) | 0.6* (2000-16) | 0.6* | 0.6* | ||
Cervix | Female | All Races | 7.1 | 7.4 | 7.5 | 7.6 | -3.8* (2000-03) -1.4* (2003-13) 1.1 (2013-16) | -3.8* (2000-03) -1.5* (2003-13) 1.2 (2013-16) | 0.5 | 0.5 |
White | 7.2 | 7.5 | 7.7 | 7.7 | -4.8* (2000-03) -0.0 (2003-08) -2.2* (2008-13) 2.9* (2013-16) | -4.8* (2000-03) -0.1 (2003-08) -2.2* (2008-13) 2.8* (2013-16) | 1.6* | 1.5* | ||
Black | 7.3 | 7.8 | 7.9 | 8.1 | -2.8* (2000-16) | -2.7* (2000-16) | -2.8* | -2.7* | ||
Colon and Rectum | Male | All Races | 39.9 | 42.6 | 42.8 | 43.4 | -2.7* (2000-16) | -2.5* (2000-08) -4.1* (2008-11) -1.4* (2011-16) | -2.7* | -1.4* |
White | 38.9 | 41.6 | 42.0 | 42.4 | -3.0* (2000-12) -1.6 (2012-16) | -3.0* (2000-12) -1.4 (2012-16) | -1.6 | -1.4 | ||
Black | 46.3 | 50.6 | 51.0 | 52.5 | -2.5* (2000-16) | -2.5* (2000-16) | -2.5* | -2.5* | ||
Female | All Races | 31.3 | 33.4 | 33.6 | 34.0 | -2.0* (2000-08) -3.5* (2008-11) -1.3* (2011-16) | -2.1* (2000-08) -3.0* (2008-13) -0.2 (2013-16) | -1.3* | -0.9 | |
White | 31.0 | 33.1 | 33.5 | 33.7 | -2.4* (2000-13) -0.4 (2013-16) | -2.4* (2000-13) -0.2 (2013-16) | -0.9 | -0.8 | ||
Black | 36.4 | 39.3 | 40.1 | 40.8 | -1.3* (2000-06) -2.9* (2006-16) | -1.3* (2000-06) -2.9* (2006-16) | -2.9* | -2.9* | ||
Corpus and Uterus NOS | Female | All Races | 26.1 | 27.1 | 27.2 | 27.4 | -1.5 (2000-03) 1.4* (2003-16) | -1.5 (2000-03) 1.5* (2003-16) | 1.4* | 1.5* |
White | 26.6 | 27.6 | 27.9 | 27.9 | -1.9 (2000-03) 1.3* (2003-16) | -1.9 (2000-03) 1.3* (2003-16) | 1.3* | 1.3* | ||
Black | 25.7 | 26.9 | 27.2 | 27.6 | 2.3* (2000-16) | 2.4* (2000-16) | 2.3* | 2.4* | ||
Esophagus | Male | All Races | 6.3 | 6.8 | 6.8 | 7.0 | -1.0* (2000-16) | -1.0* (2000-16) | -1.0* | -1.0* |
White | 6.8 | 7.3 | 7.3 | 7.5 | -0.4* (2000-16) | -0.4* (2000-16) | -0.4* | -0.4* | ||
Black | 5.3 | 6.0 | 5.7 | 6.1 | -4.8* (2000-16) | -4.7* (2000-16) | -4.8* | -4.7* | ||
Female | All Races | 1.5 | 1.6 | 1.7 | 1.7 | -1.5* (2000-16) | -1.6* (2000-16) | -1.5* | -1.6* | |
White | 1.6 | 1.7 | 1.7 | 1.7 | -1.0* (2000-16) | -1.0* (2000-16) | -1.0* | -1.0* | ||
Black | 1.8 | 2.0 | 2.0 | 2.0 | -3.9* (2000-16) | -3.9* (2000-16) | -3.9* | -3.9* | ||
Hodgkin Lymphoma | Male | All Races | 2.7 | 2.8 | 2.8 | 2.9 | 1.1 (2000-07) -1.6* (2007-16) | 1.0 (2000-07) -1.5* (2007-16) | -1.6* | -1.5* |
White | 2.8 | 3.0 | 3.0 | 3.1 | 1.1 (2000-07) -1.8* (2007-16) | 1.1 (2000-07) -1.7* (2007-16) | -1.8* | -1.7* | ||
Black | 2.6 | 2.7 | 2.8 | 2.8 | 0.3 (2000-16) | 0.3 (2000-16) | 0.3 | 0.3 | ||
Female | All Races | 2.1 | 2.2 | 2.3 | 2.3 | 2.3 (2000-05) -1.6* (2005-16) | 2.3 (2000-05) -1.6* (2005-16) | -1.6* | -1.6* | |
White | 2.2 | 2.4 | 2.4 | 2.4 | 1.1 (2000-07) -2.1* (2007-16) | 2.1 (2000-05) -1.7* (2005-16) | -2.1* | -1.7* | ||
Black | 2.3 | 2.4 | 2.5 | 2.4 | 0.4 (2000-16) | 0.3 (2000-16) | 0.4 | 0.3 | ||
Kidney and Renal Pelvis | Male | All Races | 20.3 | 21.8 | 22.3 | 22.5 | 3.0* (2000-08) 0.5 (2008-16) | 3.0* (2000-08) 0.5* (2008-16) | 0.5 | 0.5* |
White | 21.0 | 22.5 | 23.1 | 23.3 | 3.0* (2000-08) 0.5* (2008-16) | 2.9* (2000-08) 0.6* (2008-16) | 0.5* | 0.6* | ||
Black | 22.3 | 24.8 | 25.0 | 26.0 | 3.2* (2000-09) -0.1 (2009-16) | 3.4* (2000-08) 0.4 (2008-16) | -0.1 | 0.4 | ||
Female | All Races | 10.1 | 10.9 | 11.1 | 11.2 | 3.6* (2000-07) 0.5 (2007-16) | 3.6* (2000-07) 0.5 (2007-16) | 0.5 | 0.5 | |
White | 10.5 | 11.3 | 11.5 | 11.6 | 3.7* (2000-07) 0.5 (2007-16) | 4.1* (2000-06) 0.7* (2006-16) | 0.5 | 0.7* | ||
Black | 12.0 | 13.3 | 13.5 | 13.9 | 3.8* (2000-09) 0.3 (2009-16) | 4.0* (2000-08) 0.8 (2008-16) | 0.3 | 0.8 | ||
Larynx | Male | All Races | 4.5 | 4.8 | 4.9 | 4.9 | -4.3* (2000-03) -1.8* (2003-11) -3.6* (2011-16) | -4.4* (2000-03) -1.7* (2003-10) -3.3* (2010-16) | -3.6* | -3.3* |
White | 4.6 | 4.8 | 4.9 | 5.0 | -2.3* (2000-16) | -2.3* (2000-16) | -2.3* | -2.3* | ||
Black | 7.0 | 7.2 | 7.5 | 7.4 | -3.3* (2000-16) | -3.3* (2000-16) | -3.3* | -3.3* | ||
Female | All Races | 1.0 | 1.0 | 1.0 | 1.0 | -2.1* (2000-16) | -2.1* (2000-16) | -2.1* | -2.1* | |
White | 1.0 | 1.1 | 1.1 | 1.1 | -2.0* (2000-16) | -2.0* (2000-16) | -2.0* | -2.0* | ||
Black | 1.3 | 1.5 | 1.4 | 1.5 | -1.9* (2000-16) | -1.7* (2000-16) | -1.9* | -1.7* | ||
Leukemia | Male | All Races | 15.1 | 17.0 | 19.1 | 18.9 | -0.4 (2000-07) 3.1 (2007-10) 0.6 (2010-16) | -0.5 (2000-07) 3.0 (2007-10) 0.4 (2010-16) | 0.6 | 0.4 |
White | 15.8 | 17.9 | 20.7 | 20.4 | -0.1 (2000-06) 1.5* (2006-16) | -0.1 (2000-06) 1.4* (2006-16) | 1.5* | 1.4* | ||
Black | 11.8 | 13.6 | 15.2 | 15.3 | 0.5 (2000-16) | 0.5 (2000-16) | 0.5 | 0.5 | ||
Female | All Races | 9.1 | 10.1 | 11.4 | 11.2 | -0.1 (2000-05) 1.3* (2005-16) | 0.8* (2000-16) | 1.3* | 0.8* | |
White | 9.6 | 10.6 | 12.4 | 12.1 | 1.1* (2000-16) | 1.0* (2000-16) | 1.1* | 1.0* | ||
Black | 7.8 | 8.8 | 10.0 | 9.9 | -1.2 (2000-07) 2.2* (2007-16) | -1.2 (2000-07) 2.2* (2007-16) | 2.2* | 2.2* | ||
Liver and Intrahepatic Bile Duct | Male | All Races | 11.5 | 13.0 | 13.9 | 13.6 | 4.3* (2000-09) 1.8* (2009-16) | 4.2* (2000-09) 2.3* (2009-14) -1.4 (2014-16) | 1.8* | 0.4 |
White | 10.4 | 11.8 | 12.6 | 12.3 | 0.4 (2000-02) 5.6* (2002-08) 3.0* (2008-14) -0.6 (2014-16) | -0.8 (2000-02) 7.6* (2002-05) 3.6* (2005-14) -2.2 (2014-16) | 1.2 | 0.6 | ||
Black | 13.8 | 15.7 | 16.7 | 16.5 | 3.2* (2000-16) | 3.1* (2000-16) | 3.2* | 3.1* | ||
Female | All Races | 4.2 | 4.7 | 5.0 | 4.9 | 3.1* (2000-16) | 2.9* (2000-16) | 3.1* | 2.9* | |
White | 3.7 | 4.2 | 4.5 | 4.4 | 0.3 (2000-03) 4.0* (2003-16) | -0.3 (2000-03) 4.3* (2003-14) -0.8 (2014-16) | 4.0* | 1.7 | ||
Black | 4.9 | 5.6 | 6.0 | 5.8 | 3.3* (2000-16) | 3.2* (2000-16) | 3.3* | 3.2* | ||
Lung and Bronchus | Male | All Races | 52.0 | 57.2 | 57.8 | 58.5 | -2.0* (2000-09) -3.2* (2009-16) | -1.9* (2000-08) -3.1* (2008-16) | -3.2* | -3.1* |
White | 51.8 | 57.2 | 57.9 | 58.6 | -1.8* (2000-08) -3.1* (2008-16) | -1.8* (2000-08) -3.1* (2008-16) | -3.1* | -3.1* | ||
Black | 65.5 | 73.7 | 73.4 | 76.0 | -2.9* (2000-16) | -2.8* (2000-16) | -2.9* | -2.8* | ||
Female | All Races | 41.1 | 44.7 | 45.6 | 45.7 | 0.1 (2000-07) -1.7* (2007-16) | 0.1 (2000-07) -1.7* (2007-16) | -1.7* | -1.7* | |
White | 43.3 | 47.2 | 48.3 | 48.3 | 0.1 (2000-07) -1.6* (2007-16) | 0.1 (2000-07) -1.7* (2007-16) | -1.6* | -1.7* | ||
Black | 39.8 | 43.8 | 44.5 | 45.2 | 1.2 (2000-06) -1.8* (2006-16) | 1.2* (2000-06) -1.8* (2006-16) | -1.8* | -1.8* | ||
Melanoma of the Skin | Male | All Races | 25.2 | 30.1 | 28.5 | 30.8 | 1.7* (2000-16) | 1.8* (2000-16) | 1.7* | 1.8* |
White | 29.9 | 35.4 | 34.9 | 37.0 | 2.0* (2000-16) | 2.0* (2000-16) | 2.0* | 2.0* | ||
Black | 0.8 | 0.9 | 1.0 | 0.9 | -0.8 (2000-16) | -0.9 (2000-16) | -0.8 | -0.9 | ||
Female | All Races | 15.7 | 18.2 | 17.7 | 18.6 | 1.4* (2000-16) | 1.4* (2000-16) | 1.4* | 1.4* | |
White | 19.4 | 22.2 | 22.5 | 23.1 | 1.7* (2000-16) | 1.7* (2000-16) | 1.7* | 1.7* | ||
Black | 0.8 | 0.8 | 0.9 | 0.8 | 0.4 (2000-16) | 0.2 (2000-16) | 0.4 | 0.2 | ||
Myeloma | Male | All Races | 7.5 | 8.3 | 9.2 | 9.1 | 1.7* (2000-16) | 1.7* (2000-16) | 1.7* | 1.7* |
White | 7.1 | 7.8 | 8.8 | 8.6 | 1.7* (2000-16) | 1.6* (2000-16) | 1.7* | 1.6* | ||
Black | 13.7 | 15.7 | 17.4 | 17.8 | 1.6* (2000-16) | 1.6* (2000-16) | 1.6* | 1.6* | ||
Female | All Races | 4.9 | 5.5 | 6.0 | 6.0 | -0.0 (2000-06) 2.2* (2006-16) | -0.1 (2000-06) 2.1* (2006-16) | 2.2* | 2.1* | |
White | 4.3 | 4.8 | 5.4 | 5.3 | -0.3 (2000-06) 2.2* (2006-16) | -0.0 (2000-07) 2.1* (2007-16) | 2.2* | 2.1* | ||
Black | 10.8 | 12.6 | 13.9 | 14.4 | 2.0* (2000-16) | 2.0* (2000-16) | 2.0* | 2.0* | ||
Non-Hodgkin Lymphoma | Male | All Races | 20.8 | 22.7 | 23.0 | 23.4 | 0.7* (2000-08) -0.5 (2008-16) | 0.8* (2000-07) -0.3* (2007-16) | -0.5 | -0.3* |
White | 21.7 | 23.7 | 24.3 | 24.7 | 1.0* (2000-07) -0.4 (2007-16) | 0.9* (2000-07) -0.3* (2007-16) | -0.4 | -0.3* | ||
Black | 16.0 | 17.4 | 18.1 | 18.2 | 0.1 (2000-16) | 0.1 (2000-16) | 0.1 | 0.1 | ||
Female | All Races | 14.4 | 15.6 | 15.9 | 16.1 | 1.1 (2000-04) -0.4* (2004-16) | 1.0 (2000-04) -0.4* (2004-16) | -0.4* | -0.4* | |
White | 15.0 | 16.3 | 16.8 | 17.0 | 0.6 (2000-06) -0.5* (2006-16) | 0.6 (2000-06) -0.4* (2006-16) | -0.5* | -0.4* | ||
Black | 11.2 | 12.1 | 12.6 | 12.6 | 0.4* (2000-16) | 0.3 (2000-16) | 0.4* | 0.3 | ||
Oral Cavity and Pharynx | Male | All Races | 16.1 | 17.1 | 17.5 | 17.5 | -0.5 (2000-05) 1.0* (2005-16) | -0.5 (2000-05) 1.0* (2005-16) | 1.0* | 1.0* |
White | 16.9 | 17.9 | 18.6 | 18.5 | 0.1 (2000-05) 1.4* (2005-16) | 1.1* (2000-16) | 1.4* | 1.1* | ||
Black | 12.5 | 13.5 | 13.8 | 14.0 | -4.3* (2000-05) -1.4* (2005-16) | -4.4* (2000-05) -1.3* (2005-16) | -1.4* | -1.3* | ||
Female | All Races | 5.8 | 6.2 | 6.3 | 6.4 | 0.1 (2000-16) | 0.1 (2000-16) | 0.1 | 0.1 | |
White | 6.0 | 6.4 | 6.6 | 6.6 | 0.4* (2000-16) | 0.4* (2000-16) | 0.4* | 0.4* | ||
Black | 4.3 | 4.8 | 4.8 | 5.0 | -0.9* (2000-16) | -0.9* (2000-16) | -0.9* | -0.9* | ||
Ovary | Female | All Races | 9.9 | 10.4 | 10.8 | 10.7 | -1.5* (2000-16) | -1.5* (2000-16) | -1.5* | -1.5* |
White | 10.3 | 10.9 | 11.3 | 11.2 | -1.6* (2000-16) | -1.6* (2000-16) | -1.6* | -1.6* | ||
Black | 8.5 | 9.1 | 9.5 | 9.5 | -0.8* (2000-16) | -0.8* (2000-16) | -0.8* | -0.8* | ||
Pancreas | Male | All Races | 12.9 | 14.1 | 14.8 | 14.4 | 0.9* (2000-16) | 0.8* (2000-16) | 0.9* | 0.8* |
White | 12.9 | 14.1 | 14.9 | 14.5 | 1.0* (2000-16) | 1.0* (2000-16) | 1.0* | 1.0* | ||
Black | 14.2 | 16.2 | 16.4 | 16.7 | 0.2 (2000-16) | 0.2 (2000-16) | 0.2 | 0.2 | ||
Female | All Races | 10.2 | 11.1 | 11.7 | 11.4 | 0.9* (2000-16) | 0.8* (2000-16) | 0.9* | 0.8* | |
White | 10.2 | 11.0 | 11.7 | 11.4 | 1.1* (2000-16) | 1.0* (2000-16) | 1.1* | 1.0* | ||
Black | 11.9 | 13.4 | 13.8 | 13.9 | 0.1 (2000-16) | 0.1 (2000-16) | 0.1 | 0.1 | ||
Prostate | Male | All Races | 94.8 | 104.7 | 107.0 | 109.1 | -1.8* (2000-10) -9.0* (2010-14) 3.0 (2014-16) | -1.8* (2000-10) -9.0* (2010-14) 3.9 (2014-16) | -3.2 | -2.7 |
White | 86.2 | 96.7 | 101.5 | 103.4 | -1.5 (2000-08) -5.8* (2008-16) | -1.9* (2000-10) -9.4* (2010-14) 4.0 (2014-16) | -5.8* | -2.9 | ||
Black | 147.7 | 165.4 | 176.3 | 179.7 | -2.0* (2000-11) -9.6* (2011-14) 3.1 (2014-16) | -2.1* (2000-11) -9.6* (2011-14) 4.0 (2014-16) | -3.5 | -3.0 | ||
Stomach | Male | All Races | 8.3 | 8.8 | 9.0 | 9.0 | -1.4* (2000-16) | -1.4* (2000-16) | -1.4* | -1.4* |
White | 7.5 | 8.0 | 8.2 | 8.2 | -1.1* (2000-16) | -1.1* (2000-16) | -1.1* | -1.1* | ||
Black | 11.3 | 12.4 | 12.4 | 12.8 | -0.7 (2000-08) -8.1 (2008-11) 2.6 (2011-14) -6.7 (2014-16) | -0.8 (2000-08) -8.1 (2008-11) 2.6 (2011-14) -5.7 (2014-16) | -2.1 | -1.6 | ||
Female | All Races | 4.8 | 5.2 | 5.2 | 5.3 | -0.6* (2000-16) | -0.5* (2000-16) | -0.6* | -0.5* | |
White | 4.2 | 4.6 | 4.6 | 4.7 | -0.3 (2000-16) | -0.2 (2000-16) | -0.3 | -0.2 | ||
Black | 6.4 | 6.7 | 7.1 | 6.9 | -1.7* (2000-16) | -1.7* (2000-16) | -1.7* | -1.7* | ||
Testis | Male | All Races | 5.6 | 5.9 | 5.9 | 6.0 | 0.8* (2000-16) | 0.8* (2000-16) | 0.8* | 0.8* |
White | 6.6 | 7.0 | 7.1 | 7.2 | 0.8* (2000-16) | 0.8* (2000-16) | 0.8* | 0.8* | ||
Black | 1.5 | 1.7 | 1.6 | 1.7 | 1.0 (2000-16) | 1.2 (2000-16) | 1.0 | 1.2 | ||
Thyroid | Male | All Races | 7.0 | 7.3 | 7.3 | 7.4 | 5.7* (2000-11) 0.9 (2011-16) | 5.7* (2000-11) 1.0 (2011-16) | 0.9 | 1.0 |
White | 7.4 | 7.7 | 7.9 | 7.9 | 6.5* (2000-09) 2.0* (2009-16) | 6.1* (2000-10) 1.5* (2010-16) | 2.0* | 1.5* | ||
Black | 3.4 | 3.6 | 3.6 | 3.7 | 3.6* (2000-16) | 3.6* (2000-16) | 3.6* | 3.6* | ||
Female | All Races | 20.3 | 21.0 | 21.3 | 21.4 | 6.9* (2000-09) 2.4* (2009-14) -1.9 (2014-16) | 6.9* (2000-09) 2.4* (2009-14) -1.8 (2014-16) | 0.2 | 0.3 | |
White | 21.6 | 22.4 | 22.9 | 22.8 | 7.1* (2000-09) 2.3* (2009-14) -1.5 (2014-16) | 7.1* (2000-09) 2.3* (2009-14) -1.6 (2014-16) | 0.4 | 0.3 | ||
Black | 12.6 | 13.1 | 13.6 | 13.5 | 5.7* (2000-14) -4.4 (2014-16) | 5.7* (2000-14) -4.5 (2014-16) | 0.6 | 0.5 | ||
Urinary Bladder | Male | All Races | 29.1 | 31.9 | 31.7 | 32.7 | 0.1 (2000-07) -1.6* (2007-16) | -0.0 (2000-07) -1.5* (2007-16) | -1.6* | -1.5* |
White | 31.6 | 34.6 | 34.9 | 35.9 | -0.3 (2000-10) -1.9* (2010-16) | 0.0 (2000-07) -1.4* (2007-16) | -1.9* | -1.4* | ||
Black | 17.3 | 19.5 | 19.4 | 20.5 | 0.4 (2000-13) -4.6 (2013-16) | -0.1 (2000-16) | -3.4 | -0.1 | ||
Female | All Races | 7.4 | 8.0 | 8.1 | 8.2 | -1.0* (2000-16) | -1.0* (2000-16) | -1.0* | -1.0* | |
White | 7.9 | 8.6 | 8.8 | 8.9 | -1.0* (2000-16) | -0.9* (2000-16) | -1.0* | -0.9* | ||
Black | 6.5 | 7.0 | 7.3 | 7.3 | -0.7* (2000-16) | -0.7* (2000-16) | -0.7* | -0.7* |